Post written by: BioTech Health X
You May Also Like
Candel Therapeutics (CADL) is a Rising Star in Cancer Immunotherapy
- BioTech Health X
- May 30, 2025
- 6 minute read
Table of Contents Hide CAN-2409 Earns RMAT and Fast Track Status on the Strength of Pivotal Phase 3…
Bluebird Bio (BLUE) Posts 108% Revenue Growth in Q1 2025 Amid Acquisition Buzz
- BioTech Health X
- May 26, 2025
- 6 minute read
Table of Contents Hide First Quarter 2025: Revenue Acceleration and Operational Improvements Signal Renewed GrowthStrategic Inflection Point: Acquisition…
Infinity Pharmaceuticals Add 2 New Members to Board of Directors
- BioTech Health X
- September 7, 2021
- 3 minute read
Table of Contents Hide About Infinity PharmaceuticalsAbout Dr. Robert Ilaria – Infinity Pharmaceuticals Chief Medical OfficerAbout Dr. Brian…
2seventy bio Secure $170 Million Extending Cash Runway Into 2025
- BioTech Health X
- March 16, 2022
- 3 minute read
Table of Contents Hide About 2seventy bio2seventy bio Financing Details2seventy bio Current Financing Position 2seventy bio (Nasdaq: TSVT),…
Gossamer Bio (GOSS) Reports Strong Q3 2024 Financial Results
- BioTech Health X
- January 14, 2025
- 6 minute read
Table of Contents Hide Impressive Financial Performance in 2024Promising Pipeline and Strategic Clinical InitiativesStrong Financial Reserves and Future…
Ginkgo Bioworks (DNA): A Leader in Synthetic Biology Driving Innovation in 2024
- BioTech Health X
- February 8, 2025
- 5 minute read
Table of Contents Hide Ginkgo’s Leadership in Synthetic Biology and Pioneering PlatforStrategic Milestones and Key PartnershipsExpanding Market Opportunities…